Lista de obras - Michael F. McEntee - Dominio Público Uruguay

A novel intradural extramedullary spinal cord tumor in young dogs.

artículo científico

Adenocarcinoma of the canine prostate: immunohistochemical examination for secretory antigens

artículo científico publicado en 1987

Azoxymethane-induced colon carcinogenesis in mice occurs independently of de novo thymidylate synthesis capacity

artículo científico publicado en 2014

Colorectal ganglioneuromatosis in a young female dog (Lhasa Apso).

artículo científico publicado en 1990

Dietary polyunsaturated fatty acids and colorectal neoplasia.

artículo científico publicado en 2002

Early versus late treatment of spinal cord compression with long-term intrathecal enzyme replacement therapy in canine mucopolysaccharidosis type I.

artículo científico publicado en 2010

Epicatechin gallate-induced expression of NAG-1 is associated with growth inhibition and apoptosis in colon cancer cells

artículo científico publicado en 2004

Erythema multiforme associated with zonisamide in a dog.

artículo científico publicado en 2015

Granulated round cell tumor of cats

artículo científico publicado en 1993

Immune tolerance improves the efficacy of enzyme replacement therapy in canine mucopolysaccharidosis I.

artículo científico publicado en 2008

Intra-articular enzyme replacement therapy with rhIDUA is safe, well-tolerated, and reduces articular GAG storage in the canine model of mucopolysaccharidosis type I.

artículo científico publicado en 2014

Intrathecal enzyme replacement therapy reduces lysosomal storage in the brain and meninges of the canine model of MPS I

scientific article published on 01 September 2004

Ki-ras mutations are an early event and correlate with tumor stage in transplacentally-induced murine lung tumors

artículo científico publicado en 1997

Large granular lymphocyte tumor in a horse

artículo científico publicado en 1989

Long-term and high-dose trials of enzyme replacement therapy in the canine model of mucopolysaccharidosis I.

artículo científico publicado en 1996

Meningocerebral hemangiomatosis resembling Sturge-Weber disease in a horse.

artículo científico publicado en 1987

Mouse lung tumors exhibit specific Ki-ras mutations following transplacental exposure to 3-methylcholanthrene

artículo científico publicado en 1996

Mthfd1 is a modifier of chemically induced intestinal carcinogenesis ⬇️

artículo científico publicado el 14 de diciembre de 2010

Nonsteroidal anti-inflammatory drug-activated gene-1 over expression in transgenic mice suppresses intestinal neoplasia

artículo científico publicado en 2006

Ocular lesions in canine mucopolysaccharidosis I and response to enzyme replacement therapy

artículo científico publicado en 2011

Peroxisome proliferator-activated receptor ligand MCC-555 suppresses intestinal polyps in ApcMin/+ mice via extracellular signal-regulated kinase and peroxisome proliferator-activated receptor-dependent pathways

artículo científico publicado en 2008

Phenotypic characterization of polygenic type 2 diabetes in TALLYHO/JngJ mice

artículo científico publicado en 2006

Replacing the enzyme alpha-L-iduronidase at birth ameliorates symptoms in the brain and periphery of dogs with mucopolysaccharidosis type I.

artículo científico publicado en 2010

Review paper: Cancer chemopreventive compounds and canine cancer.

artículo científico publicado en 2009

Selective inhibition of Delta-6 desaturase impedes intestinal tumorigenesis

artículo científico publicado en 2002

Shmt1 heterozygosity impairs folate-dependent thymidylate synthesis capacity and modifies risk of Apc(min)-mediated intestinal cancer risk.

artículo científico publicado en 2011

Suppression of tumor cell invasion by cyclooxygenase inhibitors is mediated by thrombospondin-1 via the early growth response gene Egr-1.

artículo científico

The involvement of endoplasmic reticulum stress in the suppression of colorectal tumorigenesis by tolfenamic acid

scientific article published on 08 October 2013

Transformation of non-cancerous human breast epithelial cell line MCF10A by the tobacco-specific carcinogen NNK.

artículo científico publicado en 2003

Zyflamend reduces the expression of androgen receptor in a model of castrate-resistant prostate cancer.

artículo científico publicado en 2011

Zyflamend, a combination of herbal extracts, attenuates tumor growth in murine xenograft models of prostate cancer.

artículo científico publicado en 2012

Zyflamend, a polyherbal mixture, down regulates class I and class II histone deacetylases and increases p21 levels in castrate-resistant prostate cancer cells

artículo científico publicado en 2014

Lista de obras de Michael F. McEntee

A novel intradural extramedullary spinal cord tumor in young dogs.

Adenocarcinoma of the canine prostate: immunohistochemical examination for secretory antigens

Azoxymethane-induced colon carcinogenesis in mice occurs independently of de novo thymidylate synthesis capacity

Colorectal ganglioneuromatosis in a young female dog (Lhasa Apso).

Dietary polyunsaturated fatty acids and colorectal neoplasia.

Early versus late treatment of spinal cord compression with long-term intrathecal enzyme replacement therapy in canine mucopolysaccharidosis type I.

Epicatechin gallate-induced expression of NAG-1 is associated with growth inhibition and apoptosis in colon cancer cells

Erythema multiforme associated with zonisamide in a dog.

Granulated round cell tumor of cats

Immune tolerance improves the efficacy of enzyme replacement therapy in canine mucopolysaccharidosis I.

Intra-articular enzyme replacement therapy with rhIDUA is safe, well-tolerated, and reduces articular GAG storage in the canine model of mucopolysaccharidosis type I.

Intrathecal enzyme replacement therapy reduces lysosomal storage in the brain and meninges of the canine model of MPS I

Ki-ras mutations are an early event and correlate with tumor stage in transplacentally-induced murine lung tumors

Large granular lymphocyte tumor in a horse

Long-term and high-dose trials of enzyme replacement therapy in the canine model of mucopolysaccharidosis I.

Meningocerebral hemangiomatosis resembling Sturge-Weber disease in a horse.

Mouse lung tumors exhibit specific Ki-ras mutations following transplacental exposure to 3-methylcholanthrene

Mthfd1 is a modifier of chemically induced intestinal carcinogenesis ⬇️

Nonsteroidal anti-inflammatory drug-activated gene-1 over expression in transgenic mice suppresses intestinal neoplasia

Ocular lesions in canine mucopolysaccharidosis I and response to enzyme replacement therapy

Peroxisome proliferator-activated receptor ligand MCC-555 suppresses intestinal polyps in ApcMin/+ mice via extracellular signal-regulated kinase and peroxisome proliferator-activated receptor-dependent pathways

Phenotypic characterization of polygenic type 2 diabetes in TALLYHO/JngJ mice

Replacing the enzyme alpha-L-iduronidase at birth ameliorates symptoms in the brain and periphery of dogs with mucopolysaccharidosis type I.

Review paper: Cancer chemopreventive compounds and canine cancer.

Selective inhibition of Delta-6 desaturase impedes intestinal tumorigenesis

Shmt1 heterozygosity impairs folate-dependent thymidylate synthesis capacity and modifies risk of Apc(min)-mediated intestinal cancer risk.

Suppression of tumor cell invasion by cyclooxygenase inhibitors is mediated by thrombospondin-1 via the early growth response gene Egr-1.

The involvement of endoplasmic reticulum stress in the suppression of colorectal tumorigenesis by tolfenamic acid

Transformation of non-cancerous human breast epithelial cell line MCF10A by the tobacco-specific carcinogen NNK.

Zyflamend reduces the expression of androgen receptor in a model of castrate-resistant prostate cancer.

Zyflamend, a combination of herbal extracts, attenuates tumor growth in murine xenograft models of prostate cancer.

Zyflamend, a polyherbal mixture, down regulates class I and class II histone deacetylases and increases p21 levels in castrate-resistant prostate cancer cells